当前位置: X-MOL 学术J. Enzyme Inhib. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Synthesis and evaluation of 2,4,5-trisubstitutedthiazoles as carbonic anhydrase-III inhibitors.
Journal of Enzyme inhibition and Medicinal Chemistry ( IF 5.6 ) Pub Date : 2020-07-08 , DOI: 10.1080/14756366.2020.1786820
Bilal A Al-Jaidi 1, 2 , Pran Kishore Deb 1 , Soha Taher Telfah 1 , Abdel Naser Dakkah 1 , Yazan A Bataineh 1 , Qutaiba Ahmed Al Khames Aga 1 , Mohammad A Al-Dhoun 1 , Ala' Ali Ahmad Al-Subeihi 3 , Haifa'a Marouf Odetallah 1 , Sanaa K Bardaweel 4 , Raghuprasad Mailavaram 5 , Katharigatta N Venugopala 6, 7 , Anroop B Nair 6
Affiliation  

Abstract

A series of 17 compounds (12–16 b) with 2,4,5-trisubstitutedthiazole scaffold having 5-aryl group, 4-carboxylic acid/ester moiety, and 2-amino/amido/ureido functional groups were synthesised, characterised, and evaluated for their carbonic anhydrase (CA)-III inhibitory activities using the size exclusion Hummel–Dreyer method (HDM) of chromatography. Compound 12a with a free amino group at the 2-position, carboxylic acid moiety at the 4-position, and a phenyl ring at the 5-position of the scaffold was found to be the most potent CA-III inhibitor (Ki = 0.5 μM). The presence of a carboxylic acid group at the 4-position of the scaffold was found to be crucial for the CA-III inhibitory activity. Furthermore, replacement of the free amino group with an amide and urea group resulted in a significant reduction of activity (compounds 13c and 14c, Ki = 174.1 and 186.2 μM, respectively). Thus, compound 12a (2-amino-5-phenylthiazole-4-carboxylic acid) can be considered as the lead molecule for further modification and development of more potent CA-III inhibitors.



中文翻译:


作为碳酸酐酶-III 抑制剂的 2,4,5-三取代噻唑的合成和评价。


 抽象的


合成、表征和表征了一系列 17 种具有 2,4,5-三取代噻唑支架(具有 5-芳基、4-羧酸/酯部分和 2-氨基/酰氨基/脲基官能团)的化合物 ( 12-16 b )使用尺寸排阻 Hummel-Dreyer 色谱法 (HDM) 评估其碳酸酐酶 (CA)-III 抑制活性。发现支架的 2 位有游离氨基、4 位有羧酸部分、5 位有苯环的化合物12a是最有效的 CA-III 抑制剂 ( K i = 0.5微米)。发现支架 4 位上羧酸基团的存在对于 CA-III 抑制活性至关重要。此外,用酰胺和脲基团取代游离氨基导致活性显着降低(化合物13c14cK i分别 = 174.1 和 186.2 μM)。因此,化合物12a (2-氨基-5-苯基噻唑-4-羧酸)可被视为进一步修饰和开发更有效的CA-III抑制剂的先导分子。

更新日期:2020-07-08
down
wechat
bug